Abbisko Cayman Limited announced that on April 27, 2022 Mr. Yeh Richard tendered his resignation as an executive Director and the Head of Strategic Operations of the Company, with effect from April 28, 2022 due to his other commitments which require more of his dedication. Following the resignation of Mr. Yeh, Mr. Yeh has also ceased to be a member of the remuneration committee of the Company and an authorized representative. Dr. Xu Yao-Chang, an executive Director, chief executive officer and chairman of the Board, has been appointed as a member of the Remuneration Committee with effect from April 28, 2022 to fill the vacancy following Mr. Yeh's cessation to act in the same capacity as mentioned above.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.42 HKD | +3.64% | +12.13% | -6.30% |
04-25 | Abbisko Cayman's Liver Cancer Drug Gets US FDA Orphan Drug Designation | MT |
04-24 | Abbisko Cayman Limited Announces Resignation of Tian Huimin as Joint Company Secretary | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.30% | 273M | |
-1.65% | 104B | |
+6.75% | 97.47B | |
+5.71% | 22.25B | |
-12.60% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-10.17% | 16.36B | |
+6.12% | 14.39B | |
+35.47% | 12.37B |
- Stock Market
- Equities
- 2256 Stock
- News Abbisko Cayman Limited
- Abbisko Cayman Limited Announces Executive, Board and Committee Changes